These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Will Japanese white blood be coursing through our veins? A revolution: the first synthetic blood will soon be commercialized]. Lecuyer G Servir; 1989; 37(5):270-3. PubMed ID: 2516646 [No Abstract] [Full Text] [Related]
3. [Fluorocarbons and other artificial bloods]. Faber JC Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):31-2. PubMed ID: 3802368 [No Abstract] [Full Text] [Related]
4. Blood substitutes: where do we stand with the fluorocarbon approach? Riess JG Curr Surg; 1988; 45(5):365-70. PubMed ID: 3073041 [No Abstract] [Full Text] [Related]
5. Present trends in fluorocarbon-based blood substitutes. Riess JG Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557 [No Abstract] [Full Text] [Related]
8. It's not artificial blood--but can do the work of RBCs. Schwarz T RN (For Managers); 1982 Oct; 45(12):38-41. PubMed ID: 6921842 [No Abstract] [Full Text] [Related]
9. Blood: what's new and over the horizon. Mattox KL Med Instrum; 1981; 15(4):259-60. PubMed ID: 7300702 [TBL] [Abstract][Full Text] [Related]
10. Current perspectives on blood substitutes. Gould SA; Moss G Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573 [No Abstract] [Full Text] [Related]
11. [Clinical application of fluorocarbon artificial blood in 10 cases (author's transl)]. Xiong RC Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):213-5. PubMed ID: 7261781 [No Abstract] [Full Text] [Related]
12. [Clinical experience of hemodilution with fluosol-DA (author's transl)]. Fukushima K; Nakamura M; Takemura R Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165 [No Abstract] [Full Text] [Related]
13. Blood substitutes in surgery. Cohn SM Surgery; 2000 Jun; 127(6):599-602. PubMed ID: 10840352 [No Abstract] [Full Text] [Related]
14. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice? Lamy M; Deby-Dupont G Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348 [No Abstract] [Full Text] [Related]
18. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%. Tremper KK Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785 [No Abstract] [Full Text] [Related]
19. Clinical potential of intravenously administered perfluorocarbons. Habler O; Kleen M; Messmer K Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036 [No Abstract] [Full Text] [Related]